519 related items for PubMed ID: 29775447
1. [Mycophenolate mofetil (MMF) as the first choice immunosuppressive drug in treatment of steroid-dependent nephrotic syndrome in children].
Ogarek I, Szczęsny-Choruz E, Wierzchowska-Słowiaczek E, Kwinta-Rybicka J, Stec Z, Moczulska A, Wilkosz K, Drożdż D.
Pol Merkur Lekarski; 2018 Apr 23; 44(262):192-195. PubMed ID: 29775447
[Abstract] [Full Text] [Related]
2. Mycophenolate mofetil is inferior to tacrolimus in sustaining remission in children with idiopathic steroid-resistant nephrotic syndrome.
Sinha A, Gupta A, Kalaivani M, Hari P, Dinda AK, Bagga A.
Kidney Int; 2017 Jul 23; 92(1):248-257. PubMed ID: 28318625
[Abstract] [Full Text] [Related]
3. Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome.
Bagga A, Hari P, Moudgil A, Jordan SC.
Am J Kidney Dis; 2003 Dec 23; 42(6):1114-20. PubMed ID: 14655181
[Abstract] [Full Text] [Related]
4. Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children.
Larkins NG, Liu ID, Willis NS, Craig JC, Hodson EM.
Cochrane Database Syst Rev; 2020 Apr 16; 4(4):CD002290. PubMed ID: 32297308
[Abstract] [Full Text] [Related]
5. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
Kwinta-Rybicka J, Wilkosz K, Wierzchowska-Słowiacze EK, Ogarek I, Moczulska A, Stec Z, Pełkowska A, Sancewicz-Pach K, Pietrzyk JA.
Przegl Lek; 2006 Apr 16; 63 Suppl 3():44-8. PubMed ID: 16898486
[Abstract] [Full Text] [Related]
6. Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07).
Horinouchi T, Sako M, Nakanishi K, Ishikura K, Ito S, Nakamura H, Oba MS, Nozu K, Iijima K.
BMC Nephrol; 2018 Nov 01; 19(1):302. PubMed ID: 30382824
[Abstract] [Full Text] [Related]
7. Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children.
Kang Z, Li Z, Duan C, Wu T, Xun M, Ding Y, Zhang Y, Zhang L, Yin Y.
Pediatr Nephrol; 2015 Jul 01; 30(7):1121-9. PubMed ID: 25773534
[Abstract] [Full Text] [Related]
8. Evaluation of mycophenolate mofetil or tacrolimus in children with steroid sensitive but frequently relapsing or steroid-dependent nephrotic syndrome.
Wang J, Mao J, Chen J, Fu H, Shen H, Zhu X, Liu A, Shu Q, Du L.
Nephrology (Carlton); 2016 Jan 01; 21(1):21-7. PubMed ID: 26697959
[Abstract] [Full Text] [Related]
9. Mycophenolate mofetil for treatment of idiopathic nephrotic syndrome in children.
Nickavar A, Safarzadeh AE, Sotoudeh K, Otukesh H, Hooman N.
Iran J Kidney Dis; 2012 Sep 01; 6(5):346-9. PubMed ID: 22976259
[Abstract] [Full Text] [Related]
10. Long-term outcome of Japanese children with complicated minimal change nephrotic syndrome treated with mycophenolate mofetil after cyclosporine.
Fujinaga S, Hirano D, Nishino T, Umeda C, Watanabe Y, Nakagawa M.
Pediatr Nephrol; 2019 Nov 01; 34(11):2417-2421. PubMed ID: 31435725
[Abstract] [Full Text] [Related]
11. Triple immunosuppressive therapy in steroid-resistant nephrotic syndrome children with tacrolimus resistance or tacrolimus sensitivity but frequently relapsing.
Wu B, Mao J, Shen H, Fu H, Wang J, Liu A, Gu W, Shu Q, Du L.
Nephrology (Carlton); 2015 Jan 01; 20(1):18-24. PubMed ID: 25312783
[Abstract] [Full Text] [Related]
12. Use of mycophenolate mofetil in steroid-dependent and -resistant nephrotic syndrome.
Barletta GM, Smoyer WE, Bunchman TE, Flynn JT, Kershaw DB.
Pediatr Nephrol; 2003 Aug 01; 18(8):833-7. PubMed ID: 12774223
[Abstract] [Full Text] [Related]
13. Mycophenolate mofetil in steroid-dependent idiopathic nephrotic syndrome.
Dehoux L, Hogan J, Dossier C, Fila M, Niel O, Maisin A, Macher MA, Kwon T, Baudouin V, Deschênes G.
Pediatr Nephrol; 2016 Nov 01; 31(11):2095-101. PubMed ID: 27263020
[Abstract] [Full Text] [Related]
14. Mycophenolate mofetil for sustained remission in nephrotic syndrome.
Querfeld U, Weber LT.
Pediatr Nephrol; 2018 Dec 01; 33(12):2253-2265. PubMed ID: 29750317
[Abstract] [Full Text] [Related]
15. Efficacy of mycophenolate mofetil in pediatric patients with steroid-dependent nephrotic syndrome.
Novak I, Frank R, Vento S, Vergara M, Gauthier B, Trachtman H.
Pediatr Nephrol; 2005 Sep 01; 20(9):1265-8. PubMed ID: 15942779
[Abstract] [Full Text] [Related]
16. Efficacy and safety of mycophenolate mofetil versus levamisole in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial.
Sinha A, Puraswani M, Kalaivani M, Goyal P, Hari P, Bagga A.
Kidney Int; 2019 Jan 01; 95(1):210-218. PubMed ID: 30497684
[Abstract] [Full Text] [Related]
17. Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome.
Mendizábal S, Zamora I, Berbel O, Sanahuja MJ, Fuentes J, Simon J.
Pediatr Nephrol; 2005 Jul 01; 20(7):914-9. PubMed ID: 15891923
[Abstract] [Full Text] [Related]
18. Long-term efficacy and safety of common steroid-sparing agents in idiopathic nephrotic children.
Basu B, Babu BG, Mahapatra TK.
Clin Exp Nephrol; 2017 Feb 01; 21(1):143-151. PubMed ID: 27108294
[Abstract] [Full Text] [Related]
19. Remission of relapsing childhood nephrotic syndrome with mycophenolate mofetil.
Chandra M, Susin M, Abitbol C.
Pediatr Nephrol; 2000 Mar 01; 14(3):224-6. PubMed ID: 10752763
[Abstract] [Full Text] [Related]
20. Mycophenolate mofetil therapy for children with intractable nephrotic syndrome.
Okada M, Sugimoto K, Yagi K, Yanagida H, Tabata N, Takemura T.
Pediatr Int; 2007 Dec 01; 49(6):933-7. PubMed ID: 18045300
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
